Looming E-Cigarette Regulation Could Shift Cessation Playing Field
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval as smoking cessation products is an expensive option for e-cigarette firms due to the costs of preparing and submitting an NDA to FDA’s drug center. Regulation under the agency’s tobacco center could lead to modified risk status, but might make the NDA route more appealing.